Literature DB >> 24897088

Pharmacology and the treatment of complicated skin and skin-structure infections.

Henry F Chambers1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24897088     DOI: 10.1056/NEJMe1405078

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models.

Authors:  Catharine C Bulik; Ólanrewaju O Okusanya; Elizabeth A Lakota; Alan Forrest; Sujata M Bhavnani; Jennifer L Hoover; David R Andes; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 2.  Oritavancin for acute bacterial skin and skin structure infections.

Authors:  Julia A Messina; Vance G Fowler; G Ralph Corey
Journal:  Expert Opin Pharmacother       Date:  2015-03-24       Impact factor: 3.889

3.  Oritavancin diphosphate.

Authors:  Dennis J Cada; Danial E Baker
Journal:  Hosp Pharm       Date:  2014-12

4.  New agents approved for treatment of acute staphylococcal skin infections.

Authors:  Jan Tatarkiewicz; Anna Staniszewska; Magdalena Bujalska-Zadrożny
Journal:  Arch Med Sci       Date:  2016-05-11       Impact factor: 3.318

5.  Evaluation of Physician Prescribing Patterns For Antibiotics in the Treatment of Nonnecrotizing Skin and Soft Tissue Infections.

Authors:  Michael C Ezebuenyi; Fatima Brakta; Ifeanyichukwu O Onor; Daniel F Sarpong; Kendrea Bryant-Burks; Julio E Figueroa
Journal:  P T       Date:  2018-05

6.  Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.

Authors:  Daniel H Deck; Jennifer M Jordan; Thomas L Holland; Weihong Fan; Matthew A Wikler; Katherine A Sulham; G Ralph Corey
Journal:  Infect Dis Ther       Date:  2016-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.